These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33445219)

  • 1. Face transplantation: A longitudinal histological study focusing on chronic active and mucosal rejection in a series with long-term follow-up.
    Moktefi A; Hivelin M; Grimbert P; Carmagnat M; Sbidian E; Papouin B; Suberbielle C; Wolkenstein P; Bosc R; Meningaud JP; Lantieri L; Ortonne N
    Am J Transplant; 2021 Sep; 21(9):3088-3100. PubMed ID: 33445219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosa and Rejection in Facial Vascularized Composite Allotransplantation: A Systematic Review.
    Kauke M; Safi AF; Zhegibe A; Haug V; Kollar B; Nelms L; Palmer WJ; Tchiloemba B; Lian CG; Murphy GF; Pomahac B
    Transplantation; 2020 Dec; 104(12):2616-2624. PubMed ID: 32053572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary Thrombosis in the Skin: A Pathologic Hallmark of Severe/Chronic Rejection of Human Vascularized Composite Tissue Allografts?
    Kanitakis J; Petruzzo P; Gazarian A; Karayannopoulou G; Buron F; Dubois V; Thaunat O; Badet L; Morelon E
    Transplantation; 2016 Apr; 100(4):954-7. PubMed ID: 27003099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A four-year pathology review of the near total face transplant.
    Bergfeld W; Klimczak A; Stratton JS; Siemionow MZ
    Am J Transplant; 2013 Oct; 13(10):2750-64. PubMed ID: 23919328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.
    Rabant M; Boullenger F; Gnemmi V; Pellé G; Glowacki F; Hertig A; Brocheriou I; Suberbielle C; Taupin JL; Anglicheau D; Legendre C; Duong Van Huyen JP; Buob D
    Am J Transplant; 2018 Apr; 18(4):972-981. PubMed ID: 29206350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the Banff classification of early renal allograft biopsies and correlation with outcome.
    Bates WD; Davies DR; Welsh K; Gray DW; Fuggle SV; Morris PJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2364-9. PubMed ID: 10528659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic Vasculitis Associated With Mild Rejection in a Vascularized Composite Allograft Recipient: A Clinicopathological Study.
    Roy SF; Krishnan V; Trinh VQ; Collette S; Dufresne SF; Borsuk DE; Désy D
    Transplantation; 2020 Jul; 104(7):e208-e213. PubMed ID: 32235257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of C4d deposition in antibody-mediated rejection.
    Takeda A; Otsuka Y; Horike K; Inaguma D; Hiramitsu T; Yamamoto T; Nanmoku K; Goto N; Watarai Y; Uchida K; Morozumi K; Kobayashi T
    Clin Transplant; 2012 Jul; 26 Suppl 24():43-8. PubMed ID: 22747475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
    Loupy A; Haas M; Solez K; Racusen L; Glotz D; Seron D; Nankivell BJ; Colvin RB; Afrouzian M; Akalin E; Alachkar N; Bagnasco S; Becker JU; Cornell L; Drachenberg C; Dragun D; de Kort H; Gibson IW; Kraus ES; Lefaucheur C; Legendre C; Liapis H; Muthukumar T; Nickeleit V; Orandi B; Park W; Rabant M; Randhawa P; Reed EF; Roufosse C; Seshan SV; Sis B; Singh HK; Schinstock C; Tambur A; Zeevi A; Mengel M
    Am J Transplant; 2017 Jan; 17(1):28-41. PubMed ID: 27862883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts.
    Haas M
    Am J Transplant; 2018 Dec; 18(12):2849-2856. PubMed ID: 30133953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
    Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies.
    Troxell ML; Koslin DB; Norman D; Rayhill S; Mittalhenkle A
    Transplantation; 2010 Jul; 90(1):75-84. PubMed ID: 20548259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Analysis of Acute/Active Antibody-Mediated Rejection in Renal Allografts According to the Banff 2013 Classification.
    Arai T; Oguchi H; Shinoda K; Sakurabayashi K; Mikami T; Itabashi Y; Sakai K
    Nephron; 2020; 144 Suppl 1(Suppl 1):18-27. PubMed ID: 33264791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
    Haas M; Sis B; Racusen LC; Solez K; Glotz D; Colvin RB; Castro MC; David DS; David-Neto E; Bagnasco SM; Cendales LC; Cornell LD; Demetris AJ; Drachenberg CB; Farver CF; Farris AB; Gibson IW; Kraus E; Liapis H; Loupy A; Nickeleit V; Randhawa P; Rodriguez ER; Rush D; Smith RN; Tan CD; Wallace WD; Mengel M;
    Am J Transplant; 2014 Feb; 14(2):272-83. PubMed ID: 24472190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies.
    Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.
    Wiebe C; Gareau AJ; Pochinco D; Gibson IW; Ho J; Birk PE; Blydt-Hansen T; Karpinski M; Goldberg A; Storsley L; Rush DN; Nickerson PW
    Am J Transplant; 2017 Mar; 17(3):703-711. PubMed ID: 27539748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.